(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MAÂT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MAÂT

ST13

US500000079325211

Class

5, 42

Filing

79325211

Registration

7070571

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

11/14/2025

Trademark type

Combined

Nice classes

5, 42

Filing date

09/28/2021

Registration date

06/06/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/06/2023

Last transaction

11/14/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

FR

Examiner

SEVERSON,JUSTIN

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the letters "MA" above the letters "AT". The letters "M" and "T" are in dark blue and each letter "A" is light blue. To the right of the letters is a light blue vertical line. To the left of the lower letter "A" is a stylized light blue feather design. Above the lower letter "A" is a light blue circumflex. The color white represents background and is not claimed as a part of the mark.

Holders and representatives

Holders

M. P. (pessoa física)

Representatives

Jeffrey H. Greger Hauptman Ham, LLP

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and veterinary productspreparations for the treatment of gut dysbiosis related diseases; chemical preparations for medical or pharmaceutical usefor the treatment of gut dysbiosis related diseases; chemical preparations for pharmaceutical or medical usenamely microbiotherapy preparations for intestinal microbiome repair; bacteriological preparations for medical or veterinary use; bacterial preparations for medical or veterinary use; biological preparations for medical or veterinary use; culture media for bacteriology; chemico-pharmaceutical productsfor the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use for intestinal microbiome repair

Class 42

Evaluations and assessments in the fields of science and technology provided by engineers; scientific and technical research in the field of biomarkersnutritionmicrobiotherapybacteriotherapytherapies meant to have an effect on the gut microbiota functions; research and development of new products for third parties; technical project studiesengineering services in the nature of technical project planning for the manufacturecontrol and traceability of pharmaceutical products having an effect on gut microbiota or biomarkers aiming at characterizing the gut microbiota; chemical analysis; chemistry serviceslaboratory research in the field of chemistry; conducting clinical trials for others; surveying engineering work; scientific laboratory services; research in biologybacteriologychemistry and physics; scientific research in the field of microbiotherapy

Publications

History of USPTO decisions and trademark events.

33 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/13/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/18/2023

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/03/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/06/2023

FIMP

FINAL DISPOSITION PROCESSED

09/06/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/06/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/06/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

06/06/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

05/01/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/12/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/12/2023

GPNX

NOTIFICATION PROCESSED BY IB

03/21/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/21/2023

PUBO

PUBLISHED FOR OPPOSITION

03/21/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/01/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/01/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/01/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/10/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/18/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/18/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/18/2023

RFNP

REFUSAL PROCESSED BY IB

08/17/2022

ATRV

ATTORNEY REVIEW COMPLETED

07/29/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/28/2022

RFRR

REFUSAL PROCESSED BY MPU

07/27/2022

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

07/27/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

07/01/2022

CNRT

NON-FINAL ACTION WRITTEN

06/30/2022

DOCK

ASSIGNED TO EXAMINER

06/28/2022

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

05/29/2022

MAFR

APPLICATION FILING RECEIPT MAILED

11/16/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/12/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/11/2021

Continuous trademark protection

Get notified about every new filing that threatens MAÂT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.